Description
An alkaloid with diverse biological activities; induces autophagy in HeLa, MCF-7, and HFF cells at 5 µM; inhibits PAF-, thrombin-, collagen-, ADP-, or epinephrine-induced aggregation of isolated human platelets; priming of MSCs at 5 and 10 µM reduces TNF-α secretion by RAW 264.7 cells in co-culture; ear skin transplantation of primed MSCs decreases ear levels of TNF-α in a mouse model of ear skin inflammation; increases soleus muscle levels of Glut4 and and decreases plasma glucose levels in a rat model of streptozotocin-induced diabetes
Formal name: (4aS,16aS)-3,4,4a,5,16a,17,18,19-octahydro-12,21,22,26-tetramethoxy-4,17-dimethyl-16H-1,24:6,9-dietheno-11,15-metheno-2H-pyrido[2′,3′:17,18][1,11]dioxacycloeicosino[2,3,4-ij]isoquinoline
Synonyms: (S,S)-(+)-Tetrandrine|d-Tetrandrine|NSC 77037
Molecular weight: 622.8
CAS: 518-34-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Natural Products|Alkaloids||Research Area|Cancer|Autophagy||Research Area|Cardiovascular System|Blood|Coagulation & Hemostasis||Research Area|Cardiovascular System|Blood|Thrombosis||Research Area|Cell Biology|Endomembrane System & Vesicular Trafficking|Autophagy||Research Area|Cell Biology|Stem Cell Research||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Immunology & Inflammation|Autoimmunity||Research Area|Immunology & Inflammation|Innate Immunity